Business
Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of around EUR 1 billion in tranches
Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of around EUR 1 billion in
About this update from Fresenius Medical Care Ag
[{"type":"text","content":"\nEQS-Ad-hoc: Fresenius Medical Care AG / Key word(s): Capital measures / Share buybacks\n\nFresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of around EUR 1 billion in tranches \n26-May-2026 / 08:57 CET/CEST\n\nDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.\n\nThe issuer is solely responsible for the content of this announcement.Bad Homburg, May 26, 2026 – Fresenius Medical Care AG (“Company”) has decided to conduct the next share buyback program with a volume of around EUR 1 billion (excluding ancillary costs) in tranches within 12 months after the start of the program.\nThe execution of the share buyback program in tranches is planned to commence at short notice. The shares shall be acquired on the stock exchange and are to be predominantly redeemed and, to a significantly lesser extent, may be used for allocations under incentive-based compensation plans.\nThe share buyback program is based on the authorization to purchase and use treasury shares granted by the Company’s Annual General Meeting on May 21, 2026.\nContact:\nDr. Dominik K. Heger\nExecutive Vice President\nGlobal Head of Investor Relations, Market & Competition, Sustainability\n& Head of Investor Relations\nFresenius Medical Care AG\nElse-Kroener-Strasse 1, 61352 Bad Homburg v.d. Hoehe, Germany\nP +49 6172 2685822\[email protected]\nwww.FreseniusMedicalCare.comEnd of Inside Information\n26-May-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.\nView original content: EQS NewsLanguage:\n\tEnglishCompany:\n\tFresenius Medical Care AG \n\tElse-Kröner-Straße 1\n\t61352 Bad Homburg\n\tGermanyPhone:\n\t+49 (0) 6172- 609 2525Fax:\n\t+49 (0) 6172- 609 2301E-mail:\n\[email protected]:\n\twww.freseniusmedicalcare.comISIN:\n\tDE0005785802WKN:\n\t578580Indices:\n\tDAXListed:\n\tRegulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX; NYSE, Luxembourg Stock ExchangeEQS News ID:\n\t2333024 End of Announcement\n\tEQS News Service\n\t2333024 26-May-2026 CET/CEST","length":5410,"tagName":"div"}]